We are delighted to announce that Exploristics’ CEO, Dr Aiden Flynn, has been appointed Commercial Director on the Board of Directors at PSI, a non-profit organisation for Statisticians in the Pharmaceutical Industry. PSI promotes the importance of integrating statistical thinking into research and development in the pharmaceutical industry to improve outcomes in the sector. It provides an essential forum for statisticians to share new methodologies and ideas, as well as advancing good statistical practice within the industry.